Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 556 AL 570

Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study

Weintraub D, Papay K, Siderowf A; Parkinson's Progression Markers Initiative.

Neurology. 2013 Jan 8;80(2):176-80. doi: 10.1212/WNL.0b013e31827b915c.

Movement disorders in 2012: Advancing research towards novel therapeutic approaches

McFarland NR, Okun MS.

Nat Rev Neurol. 2013 Feb;9(2):70-1. doi: 10.1038/nrneurol.2012.265. Epub 2013 Jan 8.

Validation of the Brazilian version of the apathy inventory

Stella F, de Andrade LP, Garuffi M, Vital TM, Hernández SS, Ruocco M, Sé EV, Klein M, Martins T, Robert PH.

Int J Geriatr Psychiatry. 2013 Sep;28(9):979-86. doi: 10.1002/gps.3917. Epub 2013 Jan 7.

Hedonic tone and its mood and cognitive correlates in Parkinson's disease

Spalletta G, Fagioli S, Meco G, Pierantozzi M, Stefani A, Pisani V, Caltagirone C, Pontieri FE, Assogna F.

Depress Anxiety. 2013 Jan;30(1):85-91. doi: 10.1002/da.22036.

Homeoprotein signaling in development, health, and disease: a shaking of dogmas offers challenges and promises from bench to bed

Spatazza J, Di Lullo E, Joliot A, Dupont E, Moya KL, Prochiantz A.

Pharmacol Rev. 2013 Jan 8;65(1):90-104. doi: 10.1124/pr.112.006577. Print 2013 Jan.

Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: report of 2 cases

Vitale C, Santangelo G, Erro R, Errico D, Manganelli F, Improta I, Moccia M, Barone P.

Parkinsonism Relat Disord. 2013 Apr;19(4):483-4. doi: 10.1016/j.parkreldis.2012.11.008. Epub 2013 Jan 8.

Effect of diet on serotonergic neurotransmission in depression

Shabbir F, Patel A, Mattison C, Bose S, Krishnamohan R, Sweeney E, Sandhu S, Nel W, Rais A, Sandhu R, Ngu N, Sharma S.

Neurochem Int. 2013 Feb;62(3):324-9. doi: 10.1016/j.neuint.2012.12.014. Epub 2013 Jan 7.

Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease

Zibetti M, Rizzone M, Merola A, Angrisano S, Rizzi L, Montanaro E, Cicolin A, Lopiano L.

Acta Neurol Scand. 2013 May;127(5):e28-32. doi: 10.1111/ane.12075. Epub 2013 Jan 11.

Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia

Vidal EI, Fukushima FB, Valle AP, Villas Boas PJ.

J Am Geriatr Soc. 2013 Jan;61(1):170-2. doi: 10.1111/jgs.12058.

Parkinson's disease - how do sleep and dementia interact?

Postuma RB, Gagnon JF.

Sleep Med. 2013 Feb;14(2):129-30. doi: 10.1016/j.sleep.2012.11.007. Epub 2013 Jan 10.

Neurorehabilitation in Parkinson disease

Archibald N, Miller N, Rochester L.

Handb Clin Neurol. 2013;110:435-42. doi: 10.1016/B978-0-444-52901-5.00037-X.

The year in review of clinical cardiac electrophysiology

Marcus GM, Keung E, Scheinman MM.

J Am Coll Cardiol. 2013 Feb 19;61(7):772-82. doi: 10.1016/j.jacc.2012.09.062. Epub 2013 Jan 9.

Good and bad sides of diet in Parkinson's disease

Ułamek-Kozioł M, Bogucka-Kocka A, Kocki J, Pluta R.

Nutrition. 2013 Feb;29(2):474-5. doi: 10.1016/j.nut.2012.09.013.

Is isoproterenol really required during electrophysiological study in patients with Wolff-Parkinson-White syndrome?

Pauriah M, Cismaru G, Sellal JM, De Chillou C, Brembilla-Perrot B.

J Electrocardiol. 2013 Nov-Dec;46(6):686-92. doi: 10.1016/j.jelectrocard.2012.12.019. Epub 2013 Jan 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias